Strides Pharma Science to acquire Endo’s manufacturing facility in US along with basket of ANDAs – ET HealthWorld

Strides Pharma Science on Friday said it will acquire Endo International plc‘s manufacturing facility at Chestnut Ridge, New York along with a basket of abbreviated new drug application (ANDAs) for USD 24 million. The wholly-owned subsidiaries of Strides Pharma Science have entered into definitive agreements with the subsidiaries of Endo International plc to this effect. Under the terms of the agreement, Strides will pay USD 24 million for the acquisition, the company said in a regulatory filing. “The acquisition we have announced today is a very good strategic fit for…

Read More